Literature DB >> 9399734

Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy.

J A Colleran1, R J Hawley, E E Pinnow, P F Kokkinos, R D Fletcher.   

Abstract

Electrocardiograms were recorded at baseline and regular intervals in 53 patients with myotonic dystrophy who were followed for a mean of 6.3 +/- 4.0 years. Patients with cardiac events had a significantly prolonged PR interval (p <0.001), a later age of onset of neuromuscular symptoms (p <0.05), and were older (p <0.005).

Entities:  

Mesh：

Year:  1997        PMID： 9399734     DOI： 10.1016/s0002-9149(97)00742-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  12 in total

1.  Is it possible to identify infrahissian cardiac conduction abnormalities in myotonic dystrophy by non-invasive methods?

Authors:  D Babuty; L Fauchier; D Tena-Carbi; P Poret; J Leche; M Raynaud; J P Fauchier; P Cosnay
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  Progressive atrioventricular conduction block in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; J Gehrmann; S Reddy
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

3.  QRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance.

Authors:  Saman Nazarian; David A Bluemke; Kathryn R Wagner; Menekhem M Zviman; Evrim Turkbey; Brian S Caffo; Monda Shehata; David Edwards; Barbara Butcher; Hugh Calkins; Ronald D Berger; Henry R Halperin; Gordon F Tomaselli
Journal:  Magn Reson Med       Date:  2010-07       Impact factor: 4.668

4.  Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

Authors:  N R Clarke; A D Kelion; J Nixon; D Hilton-Jones; J C Forfar
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

5.  Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.

Authors:  Saman Nazarian; Kathryn R Wagner; Brian S Caffo; Gordon F Tomaselli
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-14       Impact factor: 1.976

6.  DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.

Authors:  C I Berul; C T Maguire; M J Aronovitz; J Greenwood; C Miller; J Gehrmann; D Housman; M E Mendelsohn; S Reddy
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

7.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

Review 8.  Myotonic dystrophy: RNA pathogenesis comes into focus.

Authors:  Laura P W Ranum; John W Day
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

9.  Optical Mapping Approaches on Muscleblind-Like Compound Knockout Mice for Understanding Mechanistic Insights Into Ventricular Arrhythmias in Myotonic Dystrophy.

Authors:  Chung-Chuan Chou; Po-Cheng Chang; Yi-Chia Wei; Kuang-Yung Lee
Journal:  J Am Heart Assoc       Date:  2017-04-17       Impact factor: 5.501

10.  Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study.

Authors:  Helle Petri; Kiril Aleksov Ahtarovski; Niels Vejlstrup; John Vissing; Nanna Witting; Lars Køber; Henning Bundgaard
Journal:  J Cardiovasc Magn Reson       Date:  2014-08-01       Impact factor: 5.364
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.